[Osteomalacia and anticonvulsant therapy: serum assay of 25 hydroxy D in an epileptic population (author's transl) (proceedings)].
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D004827:Epilepsy / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood*; D010018:Osteomalacia / Q000097:blood / Q000139:chemically induced*; D010758:Phosphorus / Q000097:blood
D000927:Anticonvulsants; D006887:Hydroxycholecalciferols; D010758:Phosphorus; D000469:Alkaline Phosphatase; D002118:Calcium
Ostéomalacie des anticonvulsivants. Intérêt du dosage plasmatique de la 25 hydroxy-vitamine D dans une population d'épileptiques